Intravenous (IV) Hydration Therapy Market, By Component, By Application, By End-Use, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032

Description

REPORT HIGHLIGHT

Intravenous (IV) Hydration Therapy Market size was valued at US$ 2,678.25 Million in 2024, expanding at a CAGR of 8.1% from 2025 to 2032.

Intravenous (IV) hydration therapy involves the administration of fluids directly into a patient's bloodstream through an IV line. This method ensures rapid delivery of fluids, electrolytes, and nutrients, bypassing the digestive system for immediate absorption. IV hydration therapy is commonly used in medical settings to treat dehydration caused by conditions like vomiting, diarrhea, fever, or excessive heat exposure. It is also vital for patients recovering from surgery, illnesses, or those with chronic conditions that impair fluid absorption. The need for IV hydration therapy arises when the body cannot adequately absorb or retain fluids orally, or when rapid rehydration is necessary. It is crucial in situations where oral hydration is not effective or feasible, such as in cases of severe dehydration or electrolyte imbalances. By replenishing lost fluids and electrolytes, IV hydration helps restore normal body functions, ensuring proper circulation, temperature regulation, and nutrient transport. The importance of IV hydration therapy lies in its ability to stabilize critical patients quickly and efficiently. It prevents complications such as kidney failure, shock, and organ dysfunction that can arise from severe dehydration. Additionally, IV therapy supports recovery and enhances overall well-being, especially in emergency care, post-operative recovery, and intensive care units.

Intravenous (IV) Hydration Therapy Market- Market Dynamics

Rising Prevalence of dehydration-related conditions to drive the market growth

The rising prevalence of dehydration-related conditions is a significant driver for the growth of the IV hydration therapy market. Dehydration can result from various factors, including excessive heat, illness, malnutrition, or intense physical activity, and can lead to severe complications such as kidney failure, heat stroke, and electrolyte imbalances. With global health challenges like climate change, rising temperatures, and the increasing frequency of heatwaves, dehydration has become more common, particularly in vulnerable populations like the elderly, children, and those with chronic illnesses. In addition to environmental factors, conditions such as gastroenteritis, diabetes, and chronic kidney disease contribute to higher dehydration rates, further increasing the need for effective hydration therapies. IV hydration therapy is essential in emergency care settings, where rapid fluid and electrolyte replenishment are critical to preventing further complications. According to the World Health Organization (WHO), dehydration is responsible for 1.3 million deaths annually, with a large percentage of these deaths occurring in low- and middle-income countries. The growing awareness of the importance of rehydration therapies and the availability of more advanced IV hydration solutions are expected to drive the market's expansion.

Intravenous (IV) Hydration Therapy Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 8.1% over the forecast period (2025-2032)
Based on Component segmentation, Medicated was predicted to show maximum market share in the year 2024
Based on End-Use segmentation, Hospitals was the leading Function in 2024
On the basis of region, North America was the leading revenue generator in 2024

Intravenous (IV) Hydration Therapy Market- Segmentation Analysis:

The Global Intravenous (IV) Hydration Therapy Market is segmented on the basis of Component, Application, End-Use and Region.

The market is divided into five categories based on Component: Medicated and Non-Medicated. Medicated dominate the market due to their ability to treat specific medical conditions, such as electrolyte imbalances, infections, and malnutrition, offering targeted therapeutic benefits. Their effectiveness in critical care settings ensures higher demand and preference among healthcare providers.

The market is divided into three categories based on End-Use: Hospitals, Wellness Centres & Spas, and Home Healthcare. Hospitals dominate the market due to their central role in providing emergency and intensive care, where rapid rehydration is crucial for patient stabilization. Additionally, hospitals have the infrastructure and resources to administer specialized hydration treatments effectively.

Intravenous (IV) Hydration Therapy Market- Geographical Insights

North America holds a dominant share due to advanced healthcare facilities, high demand for emergency and critical care services, and widespread awareness about the benefits of IV hydration therapy. The U.S., in particular, has seen an increase in the use of IV hydration for medical and wellness purposes, including for managing dehydration from various conditions like heat stroke, flu, and gastrointestinal issues.In Europe, the market is growing steadily, with countries like Germany and the UK leading in healthcare advancements and a rising number of hospitals adopting IV hydration therapy for patient care. The Asia-Pacific region, particularly India and China, is experiencing rapid growth due to improving healthcare systems, rising urbanization, and an increasing prevalence of chronic diseases, leading to higher demand for hydration therapies. Latin America and the Middle East are also witnessing growth, driven by improvements in healthcare access and rising awareness of IV hydration's role in treating dehydration.

Intravenous (IV) Hydration Therapy Market- Competitive Landscape:

The competitive landscape of the intravenous (IV) hydration therapy market is characterized by the presence of several key players, ranging from established pharmaceutical companies to emerging startups specializing in healthcare solutions. Companies are focusing on strategic partnerships, mergers, acquisitions, and collaborations to enhance their product offerings and expand their market reach. In addition to large pharmaceutical firms, specialized providers of IV hydration services are gaining popularity, offering services directly to consumers, particularly in wellness and outpatient settings. These services are gaining traction as people seek hydration therapies for non-medical purposes, such as hangover recovery or athletic performance enhancement. Furthermore, advancements in IV infusion technologies, such as smart infusion pumps and improved fluid formulations, are contributing to the competitive dynamics. Companies are also investing in research and development to create more effective and specialized hydration solutions tailored to specific medical conditions, further fueling market competition. Regulatory approvals and compliance with industry standards are essential for companies to maintain a competitive edge, as the market is heavily regulated, particularly in healthcare settings. The increasing demand for IV hydration therapy, driven by factors like rising healthcare needs, growing awareness, and technological innovations, has resulted in a competitive environment where companies must innovate and adapt to evolving market trends.

Recent Developments:

In April 2024, Evocus launched its new hydration product, Evocus Hydration IV, designed to offer rapid water balance and enhanced performance with its unique Active Absorption Technology. This electrolyte drink mix, free from artificial additives and caffeine, is targeted at individuals seeking quick hydration, particularly those with active lifestyles, including athletes. Available in multiple flavors, it is positioned as a healthier alternative for boosting hydration and muscle recovery, with a focus on improving both physical and mental well-being.
In July 2024, ChromaDex announced plans to debut its pharmaceutical-grade intravenous Niagen(R) (nicotinamide riboside chloride) at leading wellness clinics starting in August, offering a faster, more effective alternative to traditional NAD+ IV therapies. The new product promises superior tolerability, a shorter infusion time, and a higher rise in NAD+ blood levels, making it a promising innovation in the growing intravenous hydration market.
In April 2024, Liquid I.V., the top powdered hydration brand in the U.S., expanded into the Australian market, offering its Hydration Multiplier to address local hydration challenges. With a strong focus on wellness, the product aims to improve hydration faster than water alone, featuring essential vitamins and electrolytes, and will be manufactured locally to meet growing demand. Unilever's acquisition of Liquid I.V. in 2020 has fueled its international growth, with the product now available in leading Australian retailers.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL INTRAVENOUS (IV) HYDRATION THERAPY MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Baxter International
Fresenius Kabi
B. Braun Melsungen AG
Pfizer company
Otsuka Pharmaceutical
Terumo Corporation
Medline Industries
Sagent Pharmaceuticals
Amgen
Vifor Pharma
ICU Medical
Chugai Pharmaceutical
Cipla
Zhejiang Hisun Pharmaceutical
Viatris
Others

GLOBAL INTRAVENOUS (IV) HYDRATION THERAPY MARKET, BY COMPONENT- MARKET ANALYSIS, 2019 - 2032

Medicated
Non-medicated

GLOBAL INTRAVENOUS (IV) HYDRATION THERAPY MARKET, BY APPLICATION - MARKET ANALYSIS, 2019 - 2032

Immune Boosters
Energy Boosters
Skin Care
Migraine
Others

GLOBAL INTRAVENOUS (IV) HYDRATION THERAPY MARKET, BY END-USE- MARKET ANALYSIS, 2019 - 2032

Hospitals
Wellness Centres & Spas
Home Healthcare

GLOBAL INTRAVENOUS (IV) HYDRATION THERAPY MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

North America
U.S.
Canada
Europe
Germany
UK
France
Italy
Spain
The Netherlands
Sweden
Russia
Poland
Rest of Europe
Asia Pacific
China
India
Japan
South Korea
Australia
Indonesia
Thailand
Philippines
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Colombia
Rest of LATAM
The Middle East and Africa
Saudi Arabia
UAE
Israel
Turkey
Algeria
Egypt
Rest of MEA

Product Code: ANV4560

1. Intravenous (IV) Hydration Therapy Market Overview

1.1. Study Scope
1.2. Market Estimation Years

2. Executive Summary

2.1. Market Snippet
- 2.1.1. Intravenous (IV) Hydration Therapy Market Snippet by Component
- 2.1.2. Intravenous (IV) Hydration Therapy Market Snippet by Application
- 2.1.3. Intravenous (IV) Hydration Therapy Market Snippet by End-Use
- 2.1.4. Intravenous (IV) Hydration Therapy Market Snippet by Country
- 2.1.5. Intravenous (IV) Hydration Therapy Market Snippet by Region
2.2. Competitive Insights

3. Intravenous (IV) Hydration Therapy Key Market Trends

3.1. Intravenous (IV) Hydration Therapy Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
3.2. Intravenous (IV) Hydration Therapy Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
3.3. Intravenous (IV) Hydration Therapy Market Opportunities
3.4. Intravenous (IV) Hydration Therapy Market Future Trends

4. Intravenous (IV) Hydration Therapy Industry Study

4.1. PEST Analysis
4.2. Porter's Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis

5. Intravenous (IV) Hydration Therapy Market: Impact of Escalating Geopolitical Tensions

5.1. Impact of COVID-19 Pandemic
5.2. Impact of Russia-Ukraine War
5.3. Impact of Middle East Conflicts

6. Intravenous (IV) Hydration Therapy Market Landscape

6.1. Intravenous (IV) Hydration Therapy Market Share Analysis, 2024
6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis

7. Intravenous (IV) Hydration Therapy Market - By Component

7.1. Overview
- 7.1.1. Segment Share Analysis, By Component, 2024 & 2032 (%)
- 7.1.2. Medicated
- 7.1.3. Non-medicated

8. Intravenous (IV) Hydration Therapy Market - By Application

8.1. Overview
- 8.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
- 8.1.2. Immune Boosters
- 8.1.3. Energy Boosters
- 8.1.4. Skin Care
- 8.1.5. Migraine
- 8.1.6. Others

9. Intravenous (IV) Hydration Therapy Market - By End-Use

9.1. Overview
- 9.1.1. Segment Share Analysis, By End-Use, 2024 & 2032 (%)
- 9.1.2. Hospitals
- 9.1.3. Wellness Centres & Spas
- 9.1.4. Home Healthcare

10. Intravenous (IV) Hydration Therapy Market- By Geography

10.1. Introduction
- 10.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
10.2. North America
- 10.2.1. Overview
- 10.2.2. Intravenous (IV) Hydration Therapy Key Manufacturers in North America
- 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.2.4. North America Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
- 10.2.5. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.2.6. North America Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.2.7. U.S.
  - 10.2.7.1. Overview
  - 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.2.7.3. U.S. Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
  - 10.2.7.4. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.2.7.5. U.S. Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.2.8. Canada
  - 10.2.8.1. Overview
  - 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.2.8.3. Canada Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
  - 10.2.8.4. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.2.8.5. Canada Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
10.3. Europe
- 10.3.1. Overview
- 10.3.2. Intravenous (IV) Hydration Therapy Key Manufacturers in Europe
- 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.3.4. Europe Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
- 10.3.5. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.3.6. Europe Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.3.7. Germany
  - 10.3.7.1. Overview
  - 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.7.3. Germany Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
  - 10.3.7.4. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.3.7.5. Germany Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.3.8. UK
  - 10.3.8.1. Overview
  - 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.8.3. UK Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
  - 10.3.8.4. UK Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.3.8.5. UK Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.3.9. France
  - 10.3.9.1. Overview
  - 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.9.3. France Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
  - 10.3.9.4. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.3.9.5. France Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.3.10. Italy
  - 10.3.10.1. Overview
  - 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.10.3. Italy Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
  - 10.3.10.4. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.3.10.5. Italy Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.3.11. Spain
  - 10.3.11.1. Overview
  - 10.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.11.3. Spain Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
  - 10.3.11.4. Spain Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.3.11.5. Spain Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.3.12. The Netherlands
  - 10.3.12.1. Overview
  - 10.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.12.3. The Netherlands Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
  - 10.3.12.4. The Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.3.12.5. The Netherlands Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.3.13. Sweden
  - 10.3.13.1. Overview
  - 10.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.13.3. Sweden Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
  - 10.3.13.4. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.3.13.5. Sweden Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.3.14. Russia
  - 10.3.14.1. Overview
  - 10.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.14.3. Russia Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
  - 10.3.14.4. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.3.14.5. Russia Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.3.15. Poland
  - 10.3.15.1. Overview
  - 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.15.3. Poland Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
  - 10.3.15.4. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.3.15.5. Poland Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.3.16. Rest of Europe
  - 10.3.16.1. Overview
  - 10.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.16.3. Rest of the Europe Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
  - 10.3.16.4. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.3.16.5. Rest of the Europe Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
10.4. Asia Pacific (APAC)
- 10.4.1. Overview
- 10.4.2. Intravenous (IV) Hydration Therapy Key Manufacturers in Asia Pacific
- 10.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.4.4. APAC Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
- 10.4.5. APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.4.6. APAC Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.4.7. China
  - 10.4.7.1. Overview
  - 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.7.3. China Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
  - 10.4.7.4. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.4.7.5. China Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.4.8. India
  - 10.4.8.1. Overview
  - 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.8.3. India Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
  - 10.4.8.4. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.4.8.5. India Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.4.9. Japan
  - 10.4.9.1. Overview
  - 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.9.3. Japan Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
  - 10.4.9.4. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.4.9.5. Japan Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.4.10. South Korea
  - 10.4.10.1. Overview
  - 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.10.3. South Korea Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
  - 10.4.10.4. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.4.10.5. South Korea Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.4.11. Australia
  - 10.4.11.1. Overview
  - 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.11.3. Australia Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
  - 10.4.11.4. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.4.11.5. Australia Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.4.12. Indonesia
  - 10.4.12.1. Overview
  - 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.12.3. Indonesia Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
  - 10.4.12.4. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.4.12.5. Indonesia Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.4.13. Thailand
  - 10.4.13.1. Overview
  - 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.13.3. Thailand Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
  - 10.4.13.4. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.4.13.5. Thailand Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.4.14. Philippines
  - 10.4.14.1. Overview
  - 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.14.3. Philippines Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
  - 10.4.14.4. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.4.14.5. Philippines Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.4.15. Rest of APAC
  - 10.4.15.1. Overview
  - 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.15.3. Rest of APAC Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
  - 10.4.15.4. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.4.15.5. Rest of APAC Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
10.5. Latin America (LATAM)
- 10.5.1. Overview
- 10.5.2. Intravenous (IV) Hydration Therapy Key Manufacturers in Latin America
- 10.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.5.4. LATAM Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
- 10.5.5. LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.5.6. LATAM Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.5.7. Brazil
  - 10.5.7.1. Overview
  - 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.7.3. Brazil Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
  - 10.5.7.4. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.5.7.5. Brazil Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.5.8. Mexico
  - 10.5.8.1. Overview
  - 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.8.3. Mexico Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
  - 10.5.8.4. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.5.8.5. Mexico Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.5.9. Argentina
  - 10.5.9.1. Overview
  - 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.9.3. Argentina Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
  - 10.5.9.4. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.5.9.5. Argentina Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.5.10. Colombia
  - 10.5.10.1. Overview
  - 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.10.3. Colombia Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
  - 10.5.10.4. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.5.10.5. Colombia Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.5.11. Rest of LATAM
  - 10.5.11.1. Overview
  - 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.11.3. Rest of LATAM Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
  - 10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.5.11.5. Rest of LATAM Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
10.6. Middle East and Africa (MEA)
- 10.6.1. Overview
- 10.6.2. Intravenous (IV) Hydration Therapy Key Manufacturers in Middle East and Africa
- 10.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.6.4. MEA Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
- 10.6.5. MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.6.6. MEA Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.6.7. Saudi Arabia
  - 10.6.7.1. Overview
  - 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.7.3. Saudi Arabia Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
  - 10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.6.7.5. Saudi Arabia Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.6.8. UAE
  - 10.6.8.1. Overview
  - 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.8.3. UAE Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
  - 10.6.8.4. UAE Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.6.8.5. UAE Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.6.9. Israel
  - 10.6.9.1. Overview
  - 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.9.3. Israel Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
  - 10.6.9.4. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.6.9.5. Israel Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.6.10. Turkey
  - 10.6.10.1. Overview
  - 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.10.3. Turkey Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
  - 10.6.10.4. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.6.10.5. Turkey Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.6.11. Algeria
  - 10.6.11.1. Overview
  - 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.11.3. Algeria Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
  - 10.6.11.4. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.6.11.5. Algeria Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.6.12. Egypt
  - 10.6.12.1. Overview
  - 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.12.3. Egypt Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
  - 10.6.12.4. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.6.12.5. Egypt Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.6.13. Rest of MEA
  - 10.6.13.1. Overview
  - 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.13.3. Rest of MEA Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
  - 10.6.13.4. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.6.13.5. Rest of MEA Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Intravenous (IV) Hydration Therapy Industry

11.1. Competitive Dashboard
- 11.1.1. Competitive Benchmarking
- 11.1.2. Competitive Positioning
11.2. Company Profiles
- 11.2.1. Baxter International
- 11.2.2. Fresenius Kabi
- 11.2.3. B. Braun Melsungen AG
- 11.2.4. Pfizer company
- 11.2.5. Otsuka Pharmaceutical
- 11.2.6. Terumo Corporation
- 11.2.7. Medline Industries
- 11.2.8. Sagent Pharmaceuticals
- 11.2.9. Amgen
- 11.2.10. Vifor Pharma
- 11.2.11. ICU Medical
- 11.2.12. Chugai Pharmaceutical
- 11.2.13. Cipla
- 11.2.14. Zhejiang Hisun Pharmaceutical
- 11.2.15. Viatris
- 11.2.16. Others

12. 360 Degree AnalystView

13. Appendix

13.1. Research Methodology
13.2. References
13.3. Abbreviations
13.4. Disclaimer
13.5. Contact Us